Skip to main content
padlock icon - secure page this page is secure
Recent Patents on Anti-Cancer Drug Discovery publishes review articles on recent patents in the field of anti-cancer drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery.

Publisher: Bentham Science Publishers

More about this publication?
Volume 9, Number 3, 2014

Articles

Targeting Hormonal Signaling Pathways in Castration Resistant Prostate Cancer
pp. 267-285(19)
Authors: Manea, Marilena; Montagnani Marelli, Marina; M. Moretti, Roberta; Maggi, Roberto; Marzagalli, Monica; Limonta, Patrizia

Favourites:
ADD

MicroRNA Therapeutics: The Emerging Anticancer Strategies
pp. 286-296(11)
Authors: K. Jain, Chakresh; Gupta, Aman; Dogra, Nidhi; S. Kumar, Vipul; Wadhwa, Gulshan; K. Sharma, Sanjeev

Favourites:
ADD

Combination of Phytochemicals as Adjuvants for Cancer Therapy
pp. 297-302(6)
Authors: W.S. Ho, John; W.M. Cheung, Matt

Favourites:
ADD

Anticancer Hybrids- A Patent Survey
pp. 303-339(37)
Authors: Nepali, Kunal; Sharma, Sahil; Kumar, Dinesh; Budhiraja, Abhishek; L. Dhar, Kanaya

Favourites:
ADD
Favourites:
ADD

Lung Cancer Chemotherapy, New Treatment and Related Patents
pp. 372-381(10)
Authors: Cheepsattayakorn, Attapon; Cheepsattayakorn, Ruangrong

Favourites:
ADD

Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib
pp. 382-393(12)
Authors: Kumar, Suresh; Agrawal, Ritesh

Favourites:
ADD

Free Content Patent Selections:
pp. 394-397(4)

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more